Hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-15Clinical Trial Update: Study of Brentuximab Vedotin (SGN-35) in Pediatric Participants With Relapsed or Refractory (r/r) Systemic Anaplastic Large-Cell Lymphoma or Hodgkin Lymphoma [Phase 1, Phase 2]
A pediatric Phase 1/2 study of brentuximab vedotin (ADCETRIS) in relapsed or refractory systemic anaplastic large cell lymphoma or Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Busulfan, Melphalan, and Thiotepa in Treating Patients Who Are Undergoing an Autologous Stem Cell Transplant for Hodgkin's or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating a conditioning regimen of busulfan, melphalan, and thiotepa for patients undergoing autologous stem cell transplant…
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma [Phase 4]
Phase 4 clinical trial update for brentuximab vedotin in relapsed or refractory Hodgkin lymphoma, with results posted.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant [Phase 2]
Phase 2 clinical trial evaluating pentostatin and lymphocyte infusion to prevent graft rejection after donor stem cell transplantation—compl…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: PD-1 Knockout EBV-CTLs for Advanced Stage Epstein-Barr Virus (EBV) Associated Malignancies [Phase 1, Phase 2]
A Phase 1/2 clinical trial is evaluating PD-1 knockout EBV-specific cytotoxic T lymphocytes for advanced EBV-associated malignancies, includ…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Avastin (Bevacizumab) Plus Adriamycin, Bleomycin, Vinblastine and Dacarbazine (ABVD) for Advanced Stage Hodgkin Lymphoma [Phase 2]
Phase 2 trial assessing Avastin (bevacizumab) added to ABVD chemotherapy for advanced-stage Hodgkin lymphoma was terminated. Results have be…
-
CLINICAL_TRIALS trial_result · 2017-04-20Clinical Trial Update: Rituximab in Treating Patients With Hodgkin's Lymphoma [Phase 2]
A Phase 2 clinical trial evaluating rituximab in Hodgkin lymphoma has completed; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-07Clinical Trial Update: A Safety and Tolerability Study of CDX-301 With or Without Plerixafor for Stem Cell Mobilization in Matched Related Allogeneic Donor/Recipient Sibling Transplant Pairs [Phase 2]
A Phase 2 safety and tolerability trial evaluating CDX-301 with or without plerixafor for stem cell mobilization in matched related donor/re…
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Nonmyeloablative Allo SCT for the Treatment of Hematologic Disorders [Phase 2]
Phase 2 clinical trial evaluating nonmyeloablative allogeneic stem cell transplantation for various hematologic disorders has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-06Clinical Trial Update: Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma [Phase 1, Phase 2]
Results from a Phase 1/2 study evaluating brentuximab vedotin in combination with bendamustine in Hodgkin lymphoma have been posted after th…
-
CLINICAL_TRIALS trial_result · 2017-04-04Clinical Trial Update: Risk of Fatigue in Adolescent and Young Adult Hodgkin Lymphoma Patients
This clinical trial update summarizes the risk of fatigue in adolescent and young adult Hodgkin lymphoma patients from the completed NCT0122…
-
CLINICAL_TRIALS trial_result · 2017-03-31Clinical Trial Update: Plerixafor and Filgrastim For Mobilization of Donor Peripheral Blood Stem Cells Before A Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies [NA]
A terminated clinical trial evaluated mobilizing donor peripheral blood stem cells with plerixafor and filgrastim before donor transplant in…
-
CLINICAL_TRIALS trial_result · 2017-03-30Clinical Trial Update: A Phase II Study VEPEMB In Patients With Hodgkin's Lymphoma Aged ≥ 60 Years [Phase 2]
A Phase II clinical trial evaluating VEPEMB in patients with Hodgkin lymphoma aged 60 years and older has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-22Clinical Trial Update: Bendamustine Hydrochloride, Clofarabine, and Etoposide in Treating Younger Patients With Relapsed or Refractory Hematologic Malignancies [Phase 1]
A Phase 1 trial investigates a three-drug combination (bendamustine, clofarabine, and etoposide) in younger patients with relapsed or refrac…
-
CLINICAL_TRIALS trial_result · 2017-03-17Clinical Trial Update: Use of Hyperbaric Oxygen Therapy to Improve Umbilical Cord Blood Stem Cell Homing and Subsequent Engraftment [NA]
Clinical trial results posted on using hyperbaric oxygen therapy to improve umbilical cord blood stem cell homing and engraftment in patient…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: A Phase II Trial of Panobinostat and Lenalidomide in Patients With Relapsed or Refractory Hodgkin's Lymphoma [Phase 2]
Phase II trial results assess the combination of panobinostat and lenalidomide in patients with relapsed or refractory Hodgkin lymphoma.
-
CLINICAL_TRIALS trial_result · 2017-03-10Clinical Trial Update: Donor Lymphocyte Infusion in Treating Patients With Persistent, Relapsed, or Progressing Cancer After Donor Hematopoietic Cell Transplant [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating donor lymphocyte infusion for patients with persistent, relapsed, or progressing cancer after donor hema…
-
CLINICAL_TRIALS trial_result · 2017-03-09Clinical Trial Update: Tandem Auto-Allo Transplant for Lymphoma [Phase 2]
Phase 2 clinical trial update on tandem auto-allo transplantation for various lymphomas, with completed status and results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: Yoga to Alleviate Fatigue, Anxiety and Pain in Adolescents During Treatment for Lymphoma or Leukemia [NA]
A pediatric oncology trial evaluated yoga to alleviate fatigue, anxiety, and pain in adolescents undergoing treatment for leukemia or lympho…
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease [Phase 3]
Phase 3 clinical trial evaluating whether adding additional chemotherapy and/or radiation therapy to standard chemotherapy improves outcomes…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease [Phase 3]
This completed Phase 3 trial evaluated radiotherapy with or without the chemotherapy combination of doxorubicin and vinblastine in early-sta…
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: T-Cell Replete Haploidentical Donor Hematopoietic Stem Cell Plus Natural Killer (NK) Cell Transplantation in Patients With Hematologic Malignancies Relapsed or Refractory Despite Previous Allogeneic Transplant [Phase 2]
Phase 2 trial of T-cell replete haploidentical donor hematopoietic stem cell transplantation with natural killer (NK) cell support in hemato…
-
CLINICAL_TRIALS trial_result · 2017-02-15Clinical Trial Update: Epstein Barr Virus (EBV) Specific Cytotoxic T-Cells, Relapsed Lymphoma, ANGEL [Phase 1]
This clinical trial update reports the completion of a Phase 1 study of ANGEL, an EBV-specific cytotoxic T-cell therapy for relapsed Epstein…
-
CLINICAL_TRIALS research · 2017-02-14Clinical Trial Update: Pilot Study Exploring the Use of Hyperbaric Oxygen in Autologous Peripheral Blood Stem Cell Transplantation [NA]
Pilot study evaluating whether hyperbaric oxygen therapy can improve outcomes during autologous peripheral blood stem cell transplantation i…